Chen L et al., 2020-05: Oesophageal squamous cell carcinoma study reporting that ivermectin degrades PAK1, suppresses tumour growth and lung metastasis in mouse models, and inhibits proliferation and migration in cell lines.
Six days latter, when tumour volume was about 100 mm3, the mice were randomly divided into two groups and intraperitoneally injected with ivermectin (5 mg/kg) or vehicle (10% ricinus oil), respectively.
n/a (HTML full text, Methods)
Chen L et al., 2020-05: Oesophageal squamous cell carcinoma study reporting that ivermectin degrades PAK1, suppresses tumour growth and lung metastasis in mouse models, and inhibits proliferation and migration in cell lines. Study type: cell lines + subcutaneous xenograft and lung metastasis models. N: not stated in the quoted passage. Country: China (Henan University, Kaifeng). Dose: 5 mg/kg intraperitoneal, 14 days; comparator: 10% ricinus oil vehicle. Funder: not stated in the record. Declared COI: 'The authors declare that there are no conflicts of interest.' Excerpt is a record of the methods field rather than prose argument (confidence kept HIGH because it is verbatim methods text). Study type: animal.
